445 related articles for article (PubMed ID: 26546406)
21. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
[TBL] [Abstract][Full Text] [Related]
22. T cell recall response of two hypothetical proteins (Rv2251 and Rv2721c) from Mycobacterium tuberculosis in healthy household contacts of TB - Possible subunit vaccine candidates.
Santhi D; Raja A
J Infect; 2016 Nov; 73(5):455-467. PubMed ID: 27404979
[TBL] [Abstract][Full Text] [Related]
23. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection.
Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D
Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901
[TBL] [Abstract][Full Text] [Related]
25. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary responses to pathogen-specific antigens in latent Mycobacterium tuberculosis infection.
Jarvela JR; Tuscano L; Lee H; Silver RF
Tuberculosis (Edinb); 2016 Jan; 96():158-64. PubMed ID: 26732045
[TBL] [Abstract][Full Text] [Related]
27. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
28. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.
Klein M; Jarosová K; Forejtová S; Bečvář R; Sedová L; Pavelka K; Simková G; Svobodová R; Hviscová K; Mann H; Půtová I; Vencovský J
Clin Exp Rheumatol; 2013; 31(1):111-7. PubMed ID: 23101473
[TBL] [Abstract][Full Text] [Related]
29. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.
Blauenfeldt T; Wagner D; Aabye M; Heyckendorf J; Lange B; Lange C; Ernst M; Ravn P; Duarte R; Morais C; Hoffmann M; Schoch OD; Dominguez J; Latorre I; Ruhwald M
Tuberculosis (Edinb); 2016 May; 98():7-12. PubMed ID: 27156612
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects.
You E; Kim MH; Lee WI; Kang SY
Tuberculosis (Edinb); 2016 Jul; 99():100-108. PubMed ID: 27450011
[TBL] [Abstract][Full Text] [Related]
32. Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring.
Essone PN; Kalsdorf B; Chegou NN; Loxton AG; Kriel M; Preyer R; Ernst M; Walzl G; Lange C
Respiration; 2014; 88(3):251-61. PubMed ID: 25171202
[TBL] [Abstract][Full Text] [Related]
33. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
[TBL] [Abstract][Full Text] [Related]
34. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
35. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of GM-CSF and IL-2 in response to long-term specific-antigen cell stimulation in patients with active and latent tuberculosis infection.
Balcells ME; Ruiz-Tagle C; Tiznado C; García P; Naves R
Tuberculosis (Edinb); 2018 Sep; 112():110-119. PubMed ID: 30205963
[TBL] [Abstract][Full Text] [Related]
37. Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.
Hur YG; Gorak-Stolinska P; Ben-Smith A; Lalor MK; Chaguluka S; Dacombe R; Doherty TM; Ottenhoff TH; Dockrell HM; Crampin AC
PLoS One; 2013; 8(11):e79742. PubMed ID: 24260295
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
[TBL] [Abstract][Full Text] [Related]
39. The assessment of cytokines in Quantiferon supernatants for the diagnosis of latent TB infection in a tribal population of Melghat, India.
Bapat PR; Husain AA; Daginawala HF; Agrawal NP; Panchbhai MS; Satav AR; Taori GM; Kashyap RS
J Infect Public Health; 2015; 8(4):329-40. PubMed ID: 25824629
[TBL] [Abstract][Full Text] [Related]
40. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
Delogu G; Vanini V; Cuzzi G; Chiacchio T; De Maio F; Battah B; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]